A. Ghajarzadeh-Wurzner

Smartphone based blood pressure measurement: accuracy of the OptiBP mobile application according to the AAMI/ESH/ISO universal validation protocol

A. Lemkaddem, M. Burnier, M. Lemay, 2021, Blood pressure monitoring.

Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects

M. Burnier, M. Pruijm, G. Wuerzner, 2022, Frontiers in Cardiovascular Medicine.

Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial

M. Burnier, M. Pruijm, B. Milani, 2020, Journal of the American Heart Association.

Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.

M. Pruijm, O. Bonny, A. Ghajarzadeh-Wurzner, 2022, Journal of the American Society of Nephrology : JASN.